At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 154 enrolled
Drug / intervention
Travoprost Intraocular Implant, high elution +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective, Randomized Phase II Study Comparing Two Elution Rates of Glaukos Travoprost Intraocular Implants to Timolol Maleate Ophthalmic Solution, USP 0.5%
In Brief
A Phase 2 clinical trial evaluating Travoprost Intraocular Implant, high elution, Travoprost Intraocular Implant, low elution, and 1 other intervention for Glaucoma Open-angle. Completed, enrolled 154 participants across 1 site.
Detailed Summary
This is a randomized trial comparing two elution doses of the Travoprost Intraocular implant to timolol ophthalmic solution.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma Open-angle
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartMar 2016
First PostedApr 2016
Primary CompletionAug 2017
Study CompletionJul 2020
TodayJul 2026
First PostedApr 28, 2016
Enrollment StartMar 29, 2016
Primary CompletionAug 1, 2017
Study CompletionJul 21, 2020
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 10.2 years ago
Interventions
Travoprost Intraocular Implant, high elutiondrug
Surgical implant placed within the eye to elute travoprost.
Travoprost Intraocular Implant, low elutiondrug
Surgical implant placed within the eye to elute travoprost
Timolol Maleate Ophthalmic Solution, 0.5%drug
Instillation of one drop of timolol in the study eye twice daily